Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Moment of Glory! The 2023 Top 100 Chinese Pharmaceutical Industry Rankings Released
Published Time：
2024-06-25
Recently, The adjustment of the 2024 National Medical Insurance Catalog has officially started. Before this, the key tasks for deepening the reform of the medical and health system in 2024 were released. In addition to the first official announcement of full-chain support for innovative drugs, adjustments to the essential drug list and the expansion of high-quality volume-based procurement are imminent...
The introduction and promotion of a series of new policies have brought new opportunities and challenges to the pharmaceutical industry. How to seize opportunities, break through difficulties, and embrace change requires collective wisdom and efforts. Tonight's event is a joint witness to the progress and glorious moments of pharmaceutical colleagues.
The "2023 Top 100 Chinese Pharmaceutical Industry Ranking" is divided into five series of rankings: "Top 100 Chinese Chemical Pharmaceutical Companies Ranking", "Top 100 Chinese Traditional Chinese Medicine Companies Ranking", "Top 20 Chinese CXO Companies Ranking", "Top 20 Chinese Medical Device (including IVD) Companies Ranking", and "Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Companies Ranking", with a total of 260 companies listed.
● 2023 Top 100 Chinese Chemical Pharmaceutical Companies Ranking: Hengrui Medicine, CSPC Pharmaceutical, and Shanghai Pharmaceuticals Group ranked the top three;
● 2023 Top 100 Chinese Traditional Chinese Medicine Companies Ranking: Guangzhou Pharmaceutical Group, Huarun Sanjiu, and China National Pharmaceutical ranked the top three;
● 2023 Top 20 Chinese CXO (including CDMO) Companies Ranking: WuXi AppTec, Tigermed, and ChemPartner ranked the top three;
● 2023 Top 20 Chinese Medical Device (including IVD) Companies Ranking: Mindray Medical, United Imaging Intelligence, and Wego ranked the top three;
● 2023 Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Companies Ranking: BeiGene, Zhifei Biological, and Changchun High & New Technology ranked the top three.
At the dinner exchange, Yu Pengfei, director of Yuekang Pharmaceutical Group Co., Ltd., and Qin Guangxia, president of Suyu Pingmin Pharmacy Chain Co., Ltd., gave speeches in turn.
Yu Pengfei, director of Yuekang Pharmaceutical Group Co., Ltd.
“In recent years, the structure of China's pharmaceutical terminal market has been gradually optimized. Under the guidance of innovation, clinical value has become an increasingly decisive factor for pharmaceutical companies in fierce market competition, and new productivity has become a new engine for industry development.” Yu Pengfei, director of Yuekang Pharmaceutical Group Co., Ltd., said that in today's high-quality development of the pharmaceutical industry, the 2024 Mise Conference's theme of "Resilience and Innovation" has extraordinary significance, and the positive signals of promoting stability through progress and establishing a foundation before breaking through have opened the curtain on a new situation. Over the past 20 years, Yuekang Pharmaceutical has steadily and practically progressed from generic drugs to a combination of generic and innovative drugs, and then to increasing investment in innovative drug research and development, setting sail towards the world's good drugs. Enterprises must use the "resilience" of unremitting progress to establish themselves, break through difficulties, and embrace change, responding to uncertainties through innovation and iteration, and promoting high-quality development with new productivity.
Qin Guangxia, president of Suyu Pingmin Pharmacy Chain Co., Ltd.
“The economic environment in 2024 will still face many challenges, and the ‘involution’ of more than 660,000 pharmacies will become even more intense.” Qin Guangxia, president of Suyu Pingmin Pharmacy Chain Co., Ltd., said that this year's economic work adheres to the general tone of pursuing progress while maintaining stability and work requirements such as promoting stability through progress and establishing a foundation before breaking through. Focusing on promoting high-quality development, efforts will be made to expand domestic demand. The development and growth of the retail pharmacy industry cannot be separated from the support of the industry. The top 100 pharmaceutical companies born tonight represent strength, quality, and consumer recognition. Moving closer to brand companies and strengthening strategic cooperation are also the consensus of pharmacies. In addition to high-quality products and services, brand pharmaceutical companies also have mature marketing systems, professional academic support, etc. Only by jointly exploring the deeper needs of the market and working together upstream and downstream can we achieve win-win results.
Now let's all watch this highly anticipated event!
Award-winning company representatives (Round 1)
Award-winning company representatives (Round 2)
Award-winning company representatives (Round 3)
Award-winning company representatives (Round 4)
Award-winning company representatives (Round 5)
Award-winning company representatives (Round 6)
This article is from: MiNet
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.